Characteristics of the group
| Age (years), BMI | 41.8 (26.3; 68.1), 24.3 (18.5; 36.3) | |
|---|---|---|
| Stage pT (pathology) | 1a1, 1a2, 1b1, 1b2, 2a1 | 9 (3.8%), 7 (3.0%), 159 (67.9%), 33 (14.1%), 25 (10.7%) |
| Tumor type | Adenocarcinoma, Adenosquamous, Squamous | 51 (21.8%), 7 (3.0%), 170 (72.6%) |
| Grade | 1, 2, 3, missing | 21 (9.0%), 96 (41.0%), 97 (41.5%), 20 (8.5%) |
| LVSI, FST, Number of LN per patient | lymphovascular space invasion, fertility sparing treatment | 100 (42.7%), 29 (12.4.%), 36.0 (4.0;59.5) |
| Type of parametrectomy | B, C1, C2, simple hyst/trachel. | 13 (5.6%), 110 (47.1%), 94 (38.2%), 25 (10.6%) |
| Type of positivity | MAC, MIC, ITC, Negative | 14 (6.0%), 17 (7.3.%), 9 (3.8%), 194 (82.9%) |
| Adjuvant treatment | 36 (15.4%) | |
| Follow up length (months) | 67.6 (8.65;127.86) | |
| Recurrence | 29 (12.4%) | |